Zinc transporter mRNA levels in Alzheimer's disease postmortem brain.

Zinc (Zn2+) is concentrated into pre-synaptic vesicles and co-released with neurotransmitter at some synapses. Zn2+ can accelerate assembly of the amyloid-β peptides (Aβ) and tau protein central to the neuropathological changes found in Alzheimer's disease (AD). Altered protein levels of the membrane Zn2+ transporters ZnT1, ZnT4, and ZnT6 have been reported in AD postmortem brain tissue. The present study analyzed mRNA levels of five established (LIV1, ZIP1, ZnT1, ZnT4, and ZnT6) and one potential (PRNP) Zn2+ transporter in human postmortem brain tissue from Braak-staged individuals with AD and controls using quantitative real-time PCR. Four cortical regions (middle temporal gyrus, superior occipital gyrus, superior parietal gyrus, and superior frontal gyrus) and cerebellum were examined. PRNP mRNA levels were decreased by ∼30% in all four cortical regions examined in AD patients, but unchanged in the cerebellum. In contrast, some increases in mRNA levels of the other more established Zn2+ transporters (LIV1, ZIP1, ZnT1, ZnT6) were found in AD cortex. The ratios of the mRNA levels of LIV1, ZIP1, ZnT1, ZnT4, and ZnT6/mRNA level of neuron specific enolase increased significantly as the disease progressed and Braak stage increased. Significant correlations were also identified between mRNA levels of several of the Zn2+ transporters investigated. These expression changes could either reflect or cause the altered cortical Zn2+ distribution in AD, potentially increasing the likelihood of interactions between Zn2+ and Aβ or tau protein.

[1]  S. Sensi,et al.  New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc , 2011, Cell Death and Disease.

[2]  Jae-Young Koh,et al.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Sang Won Suh,et al.  Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains , 2000, Brain Research.

[4]  D. Harris,et al.  Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi , 2003, Journal of neurochemistry.

[5]  R. Colello,et al.  Developmental expression of the prion protein gene in glial cells , 1995, Neuron.

[6]  J. Velayos,et al.  The cellular prion protein and its role in Alzheimer disease , 2009, Prion.

[7]  J. Collinge,et al.  Location and properties of metal-binding sites on the human prion protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Metherate,et al.  A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses , 2009, The Journal of Neuroscience.

[9]  H. Budka,et al.  Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  A. Aguzzi,et al.  Association between Deposition of Beta-Amyloid and Pathological Prion Protein in Sporadic Creutzfeldt-Jakob Disease , 2008, Neurodegenerative Diseases.

[11]  A. Bush,et al.  Cognitive Loss in Zinc Transporter-3 Knock-Out Mice: A Phenocopy for the Synaptic and Memory Deficits of Alzheimer's Disease? , 2010, The Journal of Neuroscience.

[12]  P. S. St George-Hyslop,et al.  p53-Dependent Transcriptional Control of Cellular Prion by Presenilins , 2009, The Journal of Neuroscience.

[13]  R. Cousins,et al.  Mammalian zinc transporters. , 1998, Annual review of nutrition.

[14]  H. Kettenmann,et al.  ZnT‐1 expression in astroglial cells protects against zinc toxicity and slows the accumulation of intracellular zinc , 2004, Glia.

[15]  N. Hooper,et al.  Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region , 2001, Current Biology.

[16]  K Dheda,et al.  Real-time RT-PCR normalisation; strategies and considerations , 2005, Genes and Immunity.

[17]  W. D. Ehmann,et al.  Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress , 1996, Journal of the Neurological Sciences.

[18]  M. Tohyama,et al.  Expression of Zinc Transporter Gene, ZnT-1, Is Induced after Transient Forebrain Ischemia in the Gerbil , 1997, The Journal of Neuroscience.

[19]  R. Ravid,et al.  Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains A proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material , 1997, Journal of Neuroscience Methods.

[20]  John Hardy,et al.  The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal , 2009, Journal of neurochemistry.

[21]  P. J. Higgins,et al.  Control selection for RNA quantitation. , 2000, BioTechniques.

[22]  Antonio Lanzirotti,et al.  Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. , 2006, Journal of structural biology.

[23]  N. Hooper,et al.  Prion protein and Alzheimer disease , 2009, Prion.

[24]  U. Heinemann,et al.  Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. , 2009, Journal of Alzheimer's disease : JAD.

[25]  J. L. Smith,et al.  Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer’s disease brain , 2006, Neuroscience.

[26]  Xin Wang,et al.  Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain , 2008, Brain Research Bulletin.

[27]  M. Lovell.  A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease. , 2009, Journal of Alzheimer's Disease.

[28]  N. Hooper,et al.  Cellular prion protein regulates β-secretase cleavage of the Alzheimer's amyloid precursor protein , 2007, Proceedings of the National Academy of Sciences.

[29]  V. Haroutunian,et al.  Elevated cortical zinc in Alzheimer disease , 2006, Neurology.

[30]  W. Markesbery,et al.  Elevated Zinc Transporter-6 in Mild Cognitive Impairment, Alzheimer Disease, and Pick Disease , 2006, Journal of neuropathology and experimental neurology.

[31]  H. Braak,et al.  Staging of Alzheimer-related cortical destruction. , 1997, International psychogeriatrics.

[32]  M. Stoltenberg,et al.  Elevation of zinc transporter ZnT3 protein in the cerebellar cortex of the AbetaPP/PS1 transgenic mouse. , 2010, Journal of Alzheimer's disease : JAD.

[33]  Michaela Brenner.  Structure and Transcriptional Regulation of the GFAP Gene , 1994, Brain pathology.

[34]  C. Brayne,et al.  Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain , 2010, Neurobiology of Aging.

[35]  I. Sekler,et al.  Distribution of the zinc transporter ZnT‐1 in comparison with chelatable zinc in the mouse brain , 2002, The Journal of comparative neurology.

[36]  C. Masters,et al.  Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.

[37]  John W. Gilbert,et al.  Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.

[38]  R. Ravid,et al.  Bmc Molecular Biology Identification of Valid Reference Genes for the Normalization of Rt Qpcr Gene Expression Data in Human Brain Tissue , 2022 .

[39]  W. Markesbery,et al.  Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage alzheimer’s disease , 2009, Neurotoxicity Research.

[40]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[41]  R. Palmiter,et al.  ZnT-3, a putative transporter of zinc into synaptic vesicles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H. Kretzschmar,et al.  Microglial expression of the prion protein , 1998, Neuroreport.

[43]  A. Dahlström,et al.  Abundant expression of zinc transporters in Bergman glia of mouse cerebellum , 2005, Brain Research Bulletin.

[44]  N. Hooper,et al.  Mechanism of the metal-mediated endocytosis of the prion protein. , 2008, Biochemical Society transactions.

[45]  Jun Fan,et al.  Low Micromolar Zinc Accelerates the Fibrillization of Human Tau via Bridging of Cys-291 and Cys-322* , 2009, The Journal of Biological Chemistry.

[46]  K. Jellinger,et al.  Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease , 1998, Acta Neuropathologica.

[47]  R. Nicholson,et al.  Structure-function analysis of HKE4, a member of the new LIV-1 subfamily of zinc transporters. , 2004, The Biochemical journal.

[48]  Chan Beum Park,et al.  Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. , 2007, Biochemistry.

[49]  R. Palmiter,et al.  Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers , 2004, Pflügers Archiv.

[50]  G. Mortier,et al.  qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data , 2007, Genome Biology.

[51]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[52]  R. Ravid.  Standard Operating Procedures, ethical and legal regulations in BTB (Brain/Tissue/Bio) banking: what is still missing? , 2008, Cell and Tissue Banking.

[53]  D. Eide,et al.  Eukaryotic zinc transporters and their regulation , 2001, Biometals.

[54]  J. Hellemans,et al.  BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue. , 2011, Journal of Alzheimer's disease : JAD.

[55]  W. Markesbery,et al.  Alterations of Zinc Transporter Proteins ZnT‐1, ZnT‐4 and ZnT‐6 in Preclinical Alzheimer's Disease Brain , 2010, Brain pathology.

[56]  Liping Huang,et al.  The ZIP7 Gene (Slc39a7) Encodes a Zinc Transporter Involved in Zinc Homeostasis of the Golgi Apparatus* , 2005, Journal of Biological Chemistry.

[57]  G. Andrews,et al.  Localization of zip1 and zip4 mRNA in the adult rat brain , 2009, Journal of neuroscience research.

[58]  K. Kjaer,et al.  Zinc-amyloid beta interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species. , 2008, Journal of the American Chemical Society.

[59]  M. Stoltenberg,et al.  Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain , 2010, Neurobiology of Aging.

[60]  J. Mathers,et al.  Mechanisms of mammalian zinc-regulated gene expression. , 2008, Biochemical Society transactions.

[61]  D. Eide.  The SLC39 family of metal ion transporters , 2004, Pflügers Archiv.

[62]  V. Beneš,et al.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.

[63]  J. Hellemans,et al.  ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain , 2009, Molecular Neurodegeneration.

[64]  J. Mathers,et al.  ZnT5 Variant B Is a Bidirectional Zinc Transporter and Mediates Zinc Uptake in Human Intestinal Caco-2 Cells* , 2007, Journal of Biological Chemistry.

[65]  P. Mcgeer,et al.  The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.

[66]  J. Brandstätter,et al.  ZIP3, a New Splice Variant of the PKC-ζ-interacting Protein Family, Binds to GABAC Receptors, PKC-ζ, and Kvβ2* , 2003, The Journal of Biological Chemistry.